Effects of garlic coated tablets in peripheral arterial occlusive disease.
作者： H. Kiesewetter , F. Jung , E.M. Jung , J. Blume , C. Mrowietz
DOI: 10.1007/BF00186628
关键词: Randomized controlled trial 、 Coated tablets 、 Internal medicine 、 GARLIC POWDER 、 Placebo group 、 Peripheral arterial occlusive disease 、 Cholesterol 、 Blood pressure 、 Surgery 、 Medicine 、 Intermittent claudication 、 Gastroenterology
摘要: For the first time, a weak clinical efficacy of 12-week therapy with garlic powder (daily dose, 800 mg) is demonstrated in patients peripheral arterial occlusive disease stage II. The increase walking distance verum group by 46 m (from 161.0 ± 65.1 to 207.1 85.0 m) was significantly higher (P<0.05) than placebo (by 31 m, from 172.0 60.9 203.1 72.8). Both groups received physical twice week. diastolic blood pressure, spontaneous thrombocyte aggregation, plasma viscosity, and cholesterol concentration also decreased significantly. Body weight maintained. It quite interesting that garlic-specific did not appear occur until 5th week treatment, connected simultaneous decrease aggregation. Therefore, may be an appropriate agent especially for long-term treatment incipient intermittent claudication.
springer.com
sci-hub.se 参考文章(14)
U Bauer, 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Drug Research. ,vol. 34, pp. 716- 720 ,(1984)
Banerjee U, Ruffin J, Foushee Db, Garlic as a natural agent for the treatment of hypertension: a preliminary report. Cytobios. ,vol. 34, pp. 145- 152 ,(1982)
S.K. Chutani, Arun Bordia, The effect of fried versus raw garlic on fibrinolytic activity in man Atherosclerosis. ,vol. 38, pp. 417- 421 ,(1981) , 10.1016/0021-9150(81)90058-7
H. Bents, G. Buchkremer, Weaning from smoking. Psychological and pharmacological methods Deutsche Medizinische Wochenschrift. ,vol. 112, pp. 559- 564 ,(2008) , 10.1055/S-2008-1068098
U. Maass, H.-G. Amberger, H. Böhme, C. Diehm, H. Dimroth, H. Heidrich, F. Heinrich, H. Hirche, H. Mörl, U. Müller-Bühl, G. Rudofsky, R. Trübestein, G. Trübestein, [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration]. Deutsche Medizinische Wochenschrift. ,vol. 109, pp. 745- 750 ,(2008) , 10.1055/S-2008-1069267
D BOULLIN, GARLIC AS A PLATELET INHIBITOR The Lancet. ,vol. 317, pp. 776- 777 ,(1981) , 10.1016/S0140-6736(81)92644-1
Poul Astrup, Clinical Chemistry — Quo Vadis? Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 35, pp. 1- 3 ,(1975) , 10.1080/00365517509067997
Arun K. Bordia, H.K. Joshi, Y.K. Sanadhya, N. Bhu, Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease Atherosclerosis. ,vol. 28, pp. 155- 159 ,(1977) , 10.1016/0021-9150(77)90152-6
John M Porter, Bruce S Cutler, Bok Y Lee, Theobald Reich, Frederick A Reichle, John T Scogin, D.Eugene Strandness, Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. American Heart Journal. ,vol. 104, pp. 66- 72 ,(1982) , 10.1016/0002-8703(82)90642-1
Sainani Pg, Pise Dv, Gorhe Nh, Sainani Gs, Natu Sm, Desai Db, Effect of dietary garlic and onion on serum lipid profile in Jain community. Indian Journal of Medical Research. ,vol. 69, pp. 776- ,(1979)